skip to Main Content
Meet the Expert
Cystic Lung Disease in BHD
Highlights from the 2022 International LAM Research Conference
Chromophobe RCC: New Concepts in Pathogenesis

Ig Nobel Prize Ceremony 2017
Intro to Biomedical Research by Dr. Henske
ACT Now to Help Unlock the Cure to Tuberous Sclerosis Complex

Using Research Discoveries in Treatment

LAM: From Puzzle to Treatment

The Air We Breathe

Interview with Professor Elizabeth Henske

Understanding the Importance of Clinical Trials in Tuberous Sclerosis Complex Research

ARRA Funding at BWH

Emerging Treatments -- mTOR Inhibitors and Beyond

Lung Involvement in TSC and Treatment Options

Spotlight on Chromophobe RCC
Interview with Lisa Henske

Today’s Voice of Kidney Cancer is Dr. Elizabeth (Lisa) Henske, who runs the Henske Lab at Brigham and Women’s Hospital and Harvard Medical School in Boston. One of her principal areas of research is chromophobe renal cell carcinoma (chRCC). She’s also one of the newest members of the KCCure scientific advisory board. We’re grateful to Dr. Henske for donating her time to answer a few questions about her work in chRCC.

Back To Top